A population-based cost-effectiveness analysis of olanzapine and risperidone among ambulatory patients with schizophrenia
Journal article published in 2008 by
Dan Cooper,
Jocelyne Moisan,
Belkacem Abdous,
Jean-Pierre Grégoire 
